Fungizone For Tissue Culture Interactions
There are 175 drugs known to interact with Fungizone For Tissue Culture (amphotericin b), along with 3 disease interactions. Of the total drug interactions, 41 are major, 123 are moderate, and 11 are minor.
- View all 175 medications that may interact with Fungizone For Tissue Culture
- View Fungizone For Tissue Culture disease interactions (3)
Most frequently checked interactions
View interaction reports for Fungizone For Tissue Culture (amphotericin b) and the medicines listed below.
- Accolate (zafirlukast)
- acetaminophen
- adenosine
- Advair Diskus (fluticasone / salmeterol)
- albuterol / ipratropium
- Alvesco (ciclesonide)
- aminophylline
- Anoro Ellipta (umeclidinium / vilanterol)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Asmanex Twisthaler (mometasone)
- aspirin
- atenolol
- Atrovent (ipratropium)
- Bevespi Aerosphere (formoterol / glycopyrrolate)
- Blocadren (timolol)
- caffeine
- Chantix (varenicline)
- clindamycin
- codeine
- Combivent Respimat (albuterol / ipratropium)
- Corgard (nadolol)
- dextromethorphan
- digoxin
- dipyridamole
- Diuretic Ap-Es (hydralazine / hydrochlorothiazide / reserpine)
- dobutamine
- dopamine
- doxapram
- Dulera (formoterol / mometasone)
- DuoNeb (albuterol / ipratropium)
Fungizone For Tissue Culture disease interactions
There are 3 disease interactions with Fungizone For Tissue Culture (amphotericin b) which include:
Report options
QR code containing a link to this page
More about Fungizone For Tissue Culture (amphotericin b)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: polyenes
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.